GILD
Gilead Sciences, Inc.
Stock
$149.05−2.23 (−1.47%)Close Sep 30, 2026
| Long-term debt (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $23.8B | +7.6% | −5.0% | 0.5% |
| Long-term debt (Q2 2026) | $23.8B |
|---|---|
| YoY | +7.6% |
| 5-year CAGR | −5.0% |
| 10-year CAGR | 0.5% |
Long-term debt
| Period | Long-term debt | YoY |
|---|---|---|
| 2025 | $22.1B | −11.1% |
| 2024 | $24.9B | +7.4% |
| 2023 | $23.2B | +1.0% |
| 2022 | $23.0B | −8.8% |
| 2021 | $25.2B | −12.1% |
| 2020 | $28.6B | +29.7% |
| 2019 | $22.1B | −10.1% |
| 2018 | $24.6B | −20.2% |
| 2017 | $30.8B | +16.9% |
| 2016 | $26.3B | +25.0% |
| 2015 | $21.1B | +76.8% |
| 2014 | $11.9B | +202.6% |
| 2013 | $3.9B | −44.2% |
| 2012 | $7.1B | −7.2% |
| 2011 | $7.6B | — |